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Background: Acute kidney injury induced by renal ischaemia reperfusion injury (IRI) is characterised by renal failure,
acute tubular necrosis (ATN), inflammation and microvascular congestion. The administration of apoptotic cells
(ACs) has been shown to reduce inflammation in various organs including the liver and kidney. This study explored
whether AC administration prior to the induction of renal IRI was protective.
Findings: Renal IRI was induced in Balb/c mice by clamping the renal blood vessels for either 20, 24 or 25 minutes
to induce mild, moderate or severe kidney dysfunction respectively. Renal function and injury was determined
24 hours following IRI by measurement of plasma creatinine and ATN scoring respectively. ACs were generated
from Balb/c thymocytes and classified as either predominantly early or late apoptotic by Annexin-V and propidium
iodide staining. Early AC administration prior to severe IRI had no influence on plasma creatinine or ATN severity. In
contrast, administration of early or late ACs significantly worsened renal function in mice with mild or moderate
renal IRI, respectively, compared to PBS treated controls, though ATN scores were comparable. Despite ACs exerting
pro-coagulant effects, the worsening of renal function was not secondary to increased microvascular congestion,
inferred by fibrin and platelet (CD41) deposition, or inflammation, assessed by neutrophil infiltration.
Conclusions: Despite the AC-derived protection demonstrated in other organs, ACs do not protect mice from renal
IRI. ACs may in fact further impair renal function depending on injury severity. These data suggest that AC-derived
protection is not translationally relevant for patients with acute kidney injury induced by ischaemic injury.
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Introduction
Acute kidney injury (AKI) induced by renal ischaemia
reperfusion injury (IRI) is a significant risk factor for pa-
tients undergoing renal transplantation or any major
surgery that may transiently reduce renal blood flow.
Ischaemic AKI has a complex pathogenesis involving
acute inflammatory responses, endothelial and tubular
cell injury that determine injury severity [1-3]. Inflam-
matory responses lead to further endothelial dysfunction
and injury with increased leukocyte infiltration and re-
duced microvascular blood flow [2]. Pro-inflammatory
cytokines such as tumour necrosis factor-α (TNF-α) and
interleukin (IL)-1β are released by infiltrating leukocytes
and injured tubular epithelial cells which act to po-
tentiate inflammation and associated injury [4,5]. As* Correspondence: E.E.Hesketh@sms.ed.ac.uk
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unless otherwise stated.inflammation plays a key role following renal IRI it is
not surprising that the resultant injury may be atte-
nuated by anti-inflammatory treatments [6]. There is an
urgent need for novel treatments for AKI that reduce in-
flammation as current clinical treatments are purely sup-
portive with no specific therapy available.
Increased numbers of apoptotic cells (ACs) are found
at sites of inflammation. Surface exposure of phosphati-
dylserine (PS) on the AC surface promotes AC clearance
by macrophages [7] which facilitates the resolution of in-
flammation [8]. Macrophages that ingest ACs adopt an
anti-inflammatory phenotype with secretion of trans-
forming growth factor-β (TGF-β) and IL-10 [9]. Exogen-
ous AC administration reduces inflammation in various
experimental models including lipopolysaccharide (LPS)-
induced shock [10], collagen induced arthritis (CIA) [11]
as well as lung [12] and liver inflammation [13]. The
anti-inflammatory mechanisms of exogenous AC admin-
istration are diverse and include (i) the induction ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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the AC surface [13], (ii) the induction of IL-10 produ-
cing CD19+ regulatory B cells that stimulate a popula-
tion of IL-10 secreting antigen-specific CD4+ T cells in
CIA [11] and (iii) binding of LPS to ACs accompanied
by reduced serum TNF-α levels and increased serum
IL-10 levels in LPS shock [10]. Ren et al. also observed
suppressed neutrophil infiltration in the kidney following
AC administration in LPS-induced shock [10]. In ad-
dition, it has been shown that both apoptotic and nec-
rotic cells exert anti-inflammatory effects [14] suggesting
that these effects are not confined to intact ACs.
In view of these previous studies AC administration
may represent a novel pretreatment for AKI secondary
to renal IRI and act to limit the resultant inflammation
and tissue injury. This short study explored whether
ACs administered 24 hr prior to the induction of renal
IRI could protect Balb/c mice from functional and struc-
tural renal injury. The findings contrast with the AC-
derived protection observed in other organs and suggest
that AC administration is either neutral or, depending




Experiments were performed on male Balb/c mice aged
between 4–8 weeks (Harlan). All animal procedures were
performed under a Project License in accordance with
guidelines set out by the United Kingdom’s Home Office
under the Animal (Scientific Procedures) Act of 1986
and the University of Edinburgh’s Biological Services
Department.
Preparation and administration of viable and apoptotic
thymocytes
Dissociated thymocytes harvested from the thymi of Balb/c
mice aged 4-weeks were used fresh or incubated for 20 hr
in RPMI 1640 (PAA Laboratories) or RMPI 1640 supple-
mented with 1 μM dexamethasone (Oragon). Cell viability
was assessed by Annexin-V (BioLegend) and Propidium
Iodide (PI; Invitrogen) staining assessed by flow cytometry
on a BD Calibur cytometer. ACs were classified as either
early (Annexin-V+ PI-) or late (Annexin-V+ PI+) apoptotic.
Either PBS (control) or 20×106 viable thymocytes or ACs
was administered intravenously to mice 24 hr prior to
renal IRI.
Thymocyte phenotyping
Fresh thymocytes were prepared as described and stained
with the following anti-mouse antibodies: PE CD4 (1:200,
Clone: RM4-5, BD Pharmingen), APC CD8α (1:200,
Clone: 53-6.7, eBioscience), PerCp-Cy5.5 CD11b (1:200,
Clone: M1/70, eBiosciences) and Pacific Blue B220 (1:200,Clone: RA3-6B2, BD Pharmingen) before analysis by flow
cytometry on a BD LSR Fortessa. Isotype controls were
used to determine staining positivity.Renal IRI and assessment of renal function and acute
tubular necrosis (ATN)
Detailed methodology is described in Hesketh et al.,
[15]. In brief male 8-week Balb/c mice underwent a
contralateral right nephrectomy before the renal pedicle
was clamped with an atraumatic clamp for 22 (mild), 24
(moderate) or 25 minutes (severe injury). Body tempe-
rature was maintained at 37°C by a homeostatically con-
trolled blanket (Harvard Apparatus, Boston MA) during
the ischaemic period. The peritoneum was then sutured
and the skin closed with metallic clips and the anaes-
thesia reversed. Sham mice underwent a laparotomy
with manipulation of the left and right renal pedicle
only. Tissue and blood was collected 24 hr post-surgery
under terminal anaesthesia. Creatinine concentration
[μmol/L] was assessed in plasma samples using a crea-
tininase based method on a Cobas Fara Centrifugal
Analyser (Roche Diagnostics, UK) [15]. To determine the
ATN score the number of viable (intact cell membrane)
and necrotic tubules (compromised cell membrane) were
marked and counted in deparaffinised 4 μm kidney sec-
tions stained with H&E [15]. The number of necrotic
tubules was expressed as a percentage of the total number
of tubules (necrotic tubules %). ATN was assessed in 5
images taken at ×200 magnification of the outer stripe of
the outer medulla (OSOM) per mouse. ATN was scored
in a blinded manner.Immunohistochemistry (IHC)
Deparaffinised or frozen kidney sections, fixed in 70%
methanol, cut at a thickness of 4 μM were prepared. En-
dogenous peroxidase activity was blocked using 0.3%
H2O2 diluted in methanol. Endogenous avidin and biotin
activity was blocked using an Avidin/Biotin Blocking Kit
(Vector Laboratories). Non-specific binding was blocked
using protein block serum-free ready-to-use (Dako). Pri-
mary antibodies used were rat anti-mouse CD41 (1:250,
Clone: MWReg30, AbDserotec) and rat anti-mouse Gr1
(1:300, Clone: RB6-8C5, BioLegend). A biotinylated se-
condary rabbit anti-rat IgG (Vector Laboratories) was ap-
plied (1:300). R.T.U Vectastain Kit Elite Reagent (Vector
Laboratories) was applied before sections were exposed to
Dako Liquid DAB + Substrate Chromogen System. Sec-
tions were counterstained with Haematoxylin. Frozen sec-
tions were mounted with ProLong Gold Antifade Reagent
(Life Technologies) and paraffin sections were dehydrated
and mounted with Pertex. Negative controls without the
primary antibody and control isotype antibodies were in-
cluded (Additional file 1).
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Frozen kidney sections cut at a thickness of 4 μM were
fixed with 4% PFA 2% Acetic acid before incubation with
rabbit serum (Sigma). Polyclonal Rabbit Anti-Human
Fibrinogen/FITC (1:200, Dako Cytomation) which cross-
reacts with mouse fibrin was applied before sections
were stained with DAPI (Life Technologies). Sections
were mounted with ProLong Gold Antifade Reagent
(Life Technologies). Positive control tissue was included.
Quantification of IF and IHC staining
For each stained section 5 images of the OSOM were
taken and positive staining was selected using ImageJ
(NIH). The number of positive pixels was expressed as a
percentage of the total number of pixels [16]. Sections
were examined using either a Zeiss Axioskop 2mot + and
Hamamatsu Orca-ER camera or a Zeiss Axioskop micro-
scope and QImaging Micropublisher 3.3 RTV camera.
Quantification was performed in a blinded manner.Figure 1 Representative data illustrating the phenotype of thymocyte
thymocytes were stained with CD11b, B220, CD4 and CD8α and analysed by f
Minimal staining for B220 (A) and CD11b (B) was found. Approximately 98% o
or CD4+CD8α+ (C). Prior to administration of ACs cell viability was assessed by
Overnight culture alone induced predominantly early ACs (47% Annexin-V+ PI
late ACs (64.7% Annexin-V+ PI+) (E). Data representative of all AC preparations.Statistics
Data are expressed as mean ± SEM. Significance was
assessed by using unpaired students t test, one- or two-
way ANOVA where appropriate using Prism software
(Graphpad). P values <0.05 were considered significant.
Results
The phenotype of the fresh thymocytes used to generate
the ACs was examined by assessing the expression of
CD4, CD8, B220 (B cell marker) and CD11b (myeloid
cell marker). Minimal expression of B220 (Figure 1A)
and CD11b (Figure 1B) confirmed that cell preparations
consisted predominantly of thymocytes, 98% of which
were either CD4+, CD8α+ or CD4+CD8α+ (Figure 1C).
To explore the effects of ACs upon renal IRI either PBS
or 20×106 predominantly early ACs (Annexin-V+ PI-,
Figure 1D) or predominantly late ACs (Annexin-V+ PI+,
Figure 1E) were administered intravenously to mice 24 hr
before renal IRI. Mice were then sacrificed 24 hr later. Ins and classification of early and late ACs. Freshly isolated
low cytometry to assess the phenotype of the cells used to generate ACs.
f cells gated to exclude debris are lymphocytes and either CD4+, CD8α+
Annexin-V and Propidium Iodide (PI) staining and flow cytometry.
-) (D) whilst the addition of 1 μM dexamethasone elicited a population of
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25 mins of ischaemia but no preservation of renal function
was observed (Figure 2A). The resulting level of functional
injury was high with markedly elevated levels of plasma
creatinine and thus unlikely to be responsive to any the-
rapeutic modulation. Further studies adopted a slightly
reduced level of injury (classified according to plasma cre-
atinine). In light of work demonstrating that late ACs may
exert anti-inflammatory effects [14] the influence of late
ACs upon moderate kidney dysfunction was examined.
However, the administration of late ACs resulted in a sig-
nificant increase in plasma creatinine indicative of a wor-
sening of kidney function (Figure 2B). This suggested that
the administration of cells with significant PI positivity
was detrimental and we therefore focused upon early ACs
in a milder model of renal injury. Somewhat unexpectedly
the administration of early ACs also resulted in a sig-
nificant increase in plasma creatinine with no protection
evident (Figure 2C). On the basis of these data, we did not
examine the effects of early ACs in moderate injury or late
ACs in mild injury. ATN was evident with widespread
tubular injury in the OSOM in the ischaemic kidneys of
all PBS and AC treated mice (Figure 3A). Despite the dele-
terious effect of early or late AC administration upon
renal function in mice with mild or moderate renal IRI,
the ATN scores of PBS treated and AC treated mice were
comparable (Figure 3B). It is evident from the lower left
quadrants of Figure 1D and E that both early and late ACs
contained populations of viable non-apoptotic cells and
that these cells might be responsible for the worsening of
plasma creatinine. However, the administration of 20×106
viable thymocytes (~95% Annexin-V- PI-) prior to renal
IRI had no significant effect upon renal function measured
by plasma creatinine or ATN (Additional file 2).
The finding of unexpectedly worse renal function
without an increased ATN score in AC treated miceFigure 2 AC administration prior to moderate and mild renal IRI impa
mice by a right nephrectomy and ischaemia induced by occlusion of the le
or 20×106 early or late ACs were administered 24 hr prior to mild (20 mins
Mice were sacrificed 24 hr following IRI. (A) Administration of early ACs did no
of late ACs significantly worsened renal function in mice with moderate IRI. (C
worsened renal function. Analysed by one-way ANOVA or students t-test * =suggested that ACs might have detrimentally reduced
renal microvascular flow. The coagulation cascade is
activated following ischaemic injury [17] and the micro-
vasculature becomes congested with erythrocytes and
platelet/fibrin aggregates which aggravates tissue hypoxia
and limits the perfusion of residual viable and potentially
functional nephrons [1,18]. ACs expressing PS are pro-
coagulant and might therefore contribute to this pro-
coagulant milieu [19]. To investigate this CD41+ platelets
and fibrin were selected as markers of microvascular
congestion and their deposition assessed by IHC and IF,
respectively. CD41+ platelets and fibrin deposition was ob-
served in the OSOM of PBS and AC treated ischaemic
kidneys (Figure 4A & C), but no significant differences
between AC treated and control mice were found follo-
wing quantification (Figure 4B & D).
With increased microvascular congestion not ex-
plaining this surprising result it was speculated that AC
administration might have increased immune cell in-
filtration thereby elevating pro-inflammatory responses
post renal IRI. Neutrophils rapidly accumulate after
renal ischaemic injury [3]. They adhere to the micro-
vascular endothelium where they may obstruct the renal
microvasculature and potentially damage tubular cells by
releasing reactive oxygen species [20]. To gain an insight
into the inflammatory status, neutrophil infiltration was
determined following IHC staining for Gr1. Neutrophil
infiltration was observed in the OSOM of all ischaemic
kidneys of PBS and AC treated mice (Figure 5A), how-
ever this remained equivalent in all AC treated mice and
their corresponding PBS controls (Figure 5B).
Discussion
Although AC administration has been demonstrated to
reduce inflammation in diverse experimental models
[10-13], the data presented in this report indicates thatired renal function. Renal IRI was induced in 8-week old male Balb/c
ft renal pedicle. Sham mice underwent a laparotomy only. Either PBS
ischaemia), moderate (24 mins) or severe (25 mins) ischaemic injury.
t preserve renal function from severe IRI. (B) In contrast, administration
) Similarly, early ACs administered prior to mild ischaemia significantly
P≤ 0.05, ns = non-significant. Sham (n = 4), PBS (n = 7–8), AC (n = 8).
Figure 3 Acute tubular necrosis (ATN) following ischaemia was unaffected following AC administration. Renal IRI was induced in 8-week
old male Balb/c mice by a right nephrectomy and ischaemia induced by occluding the left renal pedicle for 20 (mild ischaemia), 24 (moderate)
or 25 mins (severe). Sham mice underwent a laparotomy only. Either PBS or 20×106 early or late ACs were administered 24 hr prior to renal IRI.
Mice were sacrificed 24 hr following IRI. (A) Representative images of the outer stripe of the outer medulla (OSOM) in non-injured and ischaemic
kidney sections stained with H&E. Tubules within the OSOM were classified as necrotic (black arrow) or healthy (grey arrow) according to cell
morphology and integrity. (Magnification: ×200; Scale Bar: 50 μM) (B) Scoring of ATN (expressed as the percentage of necrotic tubules) demonstrates
that the structural injury remained similar between PBS and AC treated mice with severe, moderate and mild ischaemic injury. Grey circle symbol =
Non-injured kidney Grey square symbol = Ischaemic kidney. Data expressed as mean ± SEM and analysed by two-way ANOVA. ns = non-significant.
Sham (n = 4), PBS (n = 7–8), AC (n = 8).
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ACs had no effect on severe renal IRI, the administra-
tion of early or late ACs prior to mild or moderate renal
IRI respectively resulted in a further increase in plasma
creatinine indicative of worse renal failure. This adverse
effect was not the result of increased structural injury as
ATN scores were comparable in PBS and AC treated
mice.
While therapeutic interventions in the renal IRI model
usually modulate both renal function and structure, func-
tional protection alone has been observed in mice ad-
ministered hemeoxygenase-1 overexpressing macrophages
[21]. This protection was considered to be secondary to a
dramatic reduction in CD41+ platelet accumulation with
improved microvascular blood flow and perfusion of non-
injured functioning nephrons. As plasma creatinine values
were higher in AC treated mice than PBS treated controls
in this study, it was hypothesized that AC treated mice
might exhibit an additional worsening of microvascular
blood flow post ischaemia. However, this was found to be
unlikely as microvascular congestion, inferred by renal
fibrin and CD41+ platelet IHC staining, was comparable
in all PBS treated and AC treated mice.It is surprising that early ACs aggravated renal function
as early ACs have generally been regarded as anti-
inflammatory in comparison to late ACs which are gener-
ally considered to be pro-inflammatory [9]. However, Gray
et al., found ACs at an early or advanced stage of apop-
tosis provided equal protection from CIA [11]. Im-
portantly, AC-derived protection does not appear to be
restricted to one cell type. The administration of between
10×106 to 30×106 apoptotic neutrophils [10], thymocytes
[11], splenocytes [13] and human Jurkat T cells [12] have
all elicited protection from inflammation in mice. In the
current short report 20×106 apoptotic thymocytes were
administered to mice 24 hr prior to renal IRI and it is un-
likely that either the AC type or number contributed to
the neutral or detrimental effect on renal function.
Apoptosis and necrosis are key events in renal tubular
cells following ischaemic injury [22] with inhibition of
apoptosis attenuating renal inflammation [23]. However,
the level of ATN did not differ between PBS and AC
treated mice indicating that increased necrosis/apop-
tosis of renal tubular cells did not occur following is-
chaemic injury. Furthermore, no discernable difference
in neutrophil infiltration was observed, suggesting that
Figure 4 Microvascular congestion remained unaffected following AC administration. Renal IRI was induced in 8-week old male Balb/c
mice by a right nephrectomy and ischaemia induced by occluding the left renal pedicle for 20 (mild ischaemia), 24 (moderate) or 25 mins
(severe). Sham mice underwent a laparotomy only. Either PBS or 20×106 early or late ACs were administered 24 hr prior to renal IRI. Mice were
sacrificed 24 hr following IRI. A & C) Representative images of the outer stripe of the outer medulla in non-injured and ischaemic kidney sections
following platelet (CD41) immunohistochemistry (A) and fibrin immunofluorescence (C) staining. In ischaemic kidneys microvascular congestion
was observed as indicated by platelet and fibrin deposition. (CD41 - Magnification: ×200 & Scale Bar: 50 μM; Fibrin - Magnification: ×400 & Scale
Bar: 25 μM) B & D) Scoring of platelet (B) and fibrin (D) staining (expressed as platelet/fibrin+ area) demonstrates that microvascular congestion
remained similar between PBS and AC treated mice with severe, moderate and mild ischaemic injury. Grey circle symbol = Non-injured kidney
Grey square symbol = Ischaemic kidney. Data expressed as mean ± SEM and analysed by two-way ANOVA. ns = non-significant. Sham (n = 4), PBS
(n = 7–8), AC (n = 8).
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Figure 5 Neutrophil infiltration occurred following ischaemia but was unaffected by AC administration. Renal IRI was induced in 8-week
old male Balb/c mice by a right nephrectomy and ischaemia induced by occluding the left renal pedicle for 20 (mild ischaemia), 24 (moderate)
or 25 mins (severe). Sham mice underwent a laparotomy only. Either PBS or 20×106 early or late ACs were administered 24 hr prior to renal IRI.
Mice were sacrificed 24 hr following IRI. (A) Representative images of the outer stripe of the outer medulla in non-injured and ischaemic kidney
sections following Gr1 staining. In ischaemic kidneys neutrophil infiltration was observed in areas of necrosis. (Magnification: ×200; Scale Bar:
50 μM) (B) Scoring of Gr1 staining (expressed as Gr1+ area) demonstrates that neutrophil infiltration remained similar between PBS and AC
treated mice with severe, moderate and mild ischaemic injury. Grey circle symbol = Non-injured kidney Grey square symbol = Ischaemic kidney.
Data expressed as mean ± SEM and analysed by two-way ANOVA. ns = non-significant. Sham (n = 4), PBS (n = 7–8), AC (n = 8).
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inflammation.
Despite previously published work demonstrating the
striking ability of ACs to modulate inflammation in mul-
tiple organs [8,10-13] this data indicates that both early
and late ACs were not protective in renal IRI. Indeed,
depending upon the severity of ischaemic injury, admin-
istration of both early and late ACs may further impair
renal function with this effect unlikely to be secondary
to any contaminating viable non-apoptotic cells in the
cell populations administered. These studies have not
extensively probed the potential mechanisms involved in
the worsening of acute kidney dysfunction by early or
late ACs. ACs express PS which, in addition to being in-
volved in the phagocytic removal of ACs, may activate
the coagulation system [24]. Also, thymocytes typically
undergo marked cell blebbing during the apoptotic
process and it is possible that they may generate many
millions of small microparticles that express PS follow-
ing intravenous administration. It is thus possible that
AC administration might modulate the coagulation sta-
tus of recipient mice and affect the microvascular re-
sponse to renal IRI. Interestingly, we did see a trend to
increased platelet and fibrin deposition in mild renal IRIfollowing administration of early ACs and moderate
renal IRI following administration of late ACs but it was
non-significant. Early ACs contained some PI positive
cells that have lost membrane integrity whilst the ma-
jority of late ACs were PI positive. Although we did not
undertake a direct head-to-head comparison of the ef-
fects of early and late ACs, it is possible that the adverse
effects of late ACs might involve the release of intra-
cellular damage-associated molecular pattern molecules
such as high-mobility group box chromosomal protein 1
that may activate cells via Toll-like receptor 4 [25]. This
work contrasts with the AC-derived protection observed
in other organs and suggests that AC administration
does not have translational potential for patients with
AKI secondary to renal hypoperfusion.Additional files
Additional file 1: Isotype controls for Gr1 and CD41 were negative
on non-injured and ischaemic kidney. Renal IRI was induced in 8-week
old male Balb/c mice by a right nephrectomy and ischaemia induced by
occluding the left renal pedicle for 24 mins. Representative images of the
outer stripe of the outer medulla in non-injured and ischaemic kidney
sections following staining with isotype control antibodies for CD41 and
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and ischaemic kidneys. (Magnification: ×200; Scale Bar: 50 μM).
Additional file 2: Administration of viable thymocytes prior to renal
IRI had no influence on renal function or ATN. Dissociated
thymocytes were prepared from 4-week old male Balb/c mice. Cell
viability was assessed by Annexin-V and Propidium Iodide (PI) staining
and flow cytometry. Either PBS or 20×106 viable non-apoptotic
thymocytes were administered to 8-week old male Balb/c mice 24 hr
prior to renal IRI induced by a right nephrectomy and occlusion of the
left renal pedicle for 20 mins. Mice were sacrificed 24 hr following IRI.
A) Viable thymocytes were approximately 94% Annexin-V- PI-.
B) Administration of viable thymocytes prior to renal IRI had no
significant influence on renal function measured by plasma creatinine.
C) Scoring of ATN (acute tubular necrosis) (expressed as the percentage
of necrotic tubules in the outer stripe of the outer medulla) demonstrates
that the structural injury remained similar between mice that received
PBS or viable thymocytes prior to renal IRI. Grey circle symbol = Non-
injured kidney Grey square symbol = Ischaemic kidney. Data expressed as
mean ± SEM and analysed by either student’s t-test or one-way ANOVA.
ns = non-significant. PBS (n = 5), Viable thymocytes (n = 5).
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